BidaskClub upgraded shares of MiMedx Group (NASDAQ:MDXG) from a sell rating to a hold rating in a report issued on Wednesday morning.
MDXG has been the subject of a number of other research reports. Piper Jaffray Companies reiterated a buy rating and issued a $18.00 price target on shares of MiMedx Group in a report on Friday, November 24th. Needham & Company LLC reiterated a buy rating and issued a $21.00 price target on shares of MiMedx Group in a report on Tuesday, November 14th. Craig Hallum reiterated a buy rating on shares of MiMedx Group in a report on Tuesday, February 27th. ValuEngine downgraded shares of MiMedx Group from a hold rating to a sell rating in a report on Thursday, March 1st. Finally, Lake Street Capital set a $18.00 price target on shares of MiMedx Group and gave the company a buy rating in a report on Thursday, December 14th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. MiMedx Group has a consensus rating of Hold and a consensus target price of $14.75.
Shares of MiMedx Group (NASDAQ MDXG) traded down $0.50 on Wednesday, hitting $7.42. 7,031,227 shares of the stock were exchanged, compared to its average volume of 5,693,082. The stock has a market cap of $823.88, a P/E ratio of 23.94 and a beta of 1.65. MiMedx Group has a 1-year low of $6.05 and a 1-year high of $18.25.
A number of large investors have recently bought and sold shares of the business. BlackRock Inc. increased its holdings in MiMedx Group by 1.1% during the 4th quarter. BlackRock Inc. now owns 13,607,325 shares of the medical equipment provider’s stock valued at $171,588,000 after acquiring an additional 147,214 shares in the last quarter. Consonance Capital Management LP purchased a new position in MiMedx Group during the 4th quarter valued at about $75,543,000. Millennium Management LLC increased its holdings in MiMedx Group by 11.5% during the 4th quarter. Millennium Management LLC now owns 2,193,907 shares of the medical equipment provider’s stock valued at $27,665,000 after acquiring an additional 226,663 shares in the last quarter. Atlantic Trust Group LLC increased its holdings in MiMedx Group by 2.6% during the 3rd quarter. Atlantic Trust Group LLC now owns 1,490,411 shares of the medical equipment provider’s stock valued at $17,706,000 after acquiring an additional 37,937 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in MiMedx Group by 1,647.9% during the 4th quarter. The Manufacturers Life Insurance Company now owns 1,405,458 shares of the medical equipment provider’s stock valued at $17,723,000 after acquiring an additional 1,325,048 shares in the last quarter. Hedge funds and other institutional investors own 78.86% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was reported by Markets Daily and is the property of of Markets Daily. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.themarketsdaily.com/2018/03/11/mimedx-group-mdxg-raised-to-hold-at-bidaskclub.html.
MiMedx Group Company Profile
MiMedx Group, Inc is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.
Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.